Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burkholderia pseudomallei | 1 | 2016 | 9 | 0.580 |
Why?
|
| Burkholderia Infections | 1 | 2016 | 44 | 0.550 |
Why?
|
| Immunity, Humoral | 5 | 2024 | 598 | 0.400 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2023 | 1832 | 0.380 |
Why?
|
| Angiotensin II | 1 | 2013 | 881 | 0.370 |
Why?
|
| HIV-1 | 4 | 2022 | 6939 | 0.360 |
Why?
|
| Host-Pathogen Interactions | 3 | 2022 | 1477 | 0.350 |
Why?
|
| HIV Antibodies | 4 | 2022 | 1322 | 0.350 |
Why?
|
| Tuberculosis | 4 | 2023 | 1912 | 0.340 |
Why?
|
| Antibodies, Bacterial | 5 | 2023 | 1470 | 0.340 |
Why?
|
| Leukemia | 1 | 2016 | 1511 | 0.310 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 4665 | 0.310 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 3176 | 0.280 |
Why?
|
| HIV Infections | 6 | 2022 | 16718 | 0.260 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2023 | 32 | 0.230 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3647 | 0.220 |
Why?
|
| Genome, Human | 1 | 2016 | 4420 | 0.220 |
Why?
|
| Antibodies, Neutralizing | 6 | 2023 | 1978 | 0.220 |
Why?
|
| Vaccines | 2 | 2023 | 822 | 0.210 |
Why?
|
| Orthomyxoviridae | 1 | 2024 | 156 | 0.210 |
Why?
|
| DNA Methylation | 1 | 2016 | 4286 | 0.210 |
Why?
|
| Shigella | 1 | 2022 | 74 | 0.210 |
Why?
|
| Dysentery, Bacillary | 1 | 2022 | 75 | 0.210 |
Why?
|
| Receptors, Fc | 2 | 2023 | 541 | 0.200 |
Why?
|
| HIV Antigens | 1 | 2021 | 347 | 0.190 |
Why?
|
| Vaccines, DNA | 2 | 2021 | 305 | 0.190 |
Why?
|
| Tuberculosis Vaccines | 1 | 2020 | 50 | 0.170 |
Why?
|
| Latent Tuberculosis | 1 | 2022 | 225 | 0.170 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2023 | 329 | 0.170 |
Why?
|
| Insulin | 1 | 2013 | 6580 | 0.170 |
Why?
|
| Virion | 1 | 2021 | 433 | 0.170 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 2 | 2018 | 370 | 0.160 |
Why?
|
| Pneumococcal Infections | 1 | 2022 | 497 | 0.150 |
Why?
|
| Models, Biological | 1 | 2013 | 9583 | 0.150 |
Why?
|
| Streptococcus pneumoniae | 1 | 2022 | 714 | 0.140 |
Why?
|
| Vibrio cholerae | 1 | 2023 | 806 | 0.140 |
Why?
|
| Diabetes Mellitus | 2 | 2021 | 5751 | 0.140 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2017 | 305 | 0.140 |
Why?
|
| Influenza Vaccines | 1 | 2024 | 738 | 0.140 |
Why?
|
| Cholera | 1 | 2023 | 785 | 0.140 |
Why?
|
| Antigens, Bacterial | 4 | 2023 | 1171 | 0.130 |
Why?
|
| Immunoglobulin G | 3 | 2023 | 4560 | 0.130 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2021 | 810 | 0.130 |
Why?
|
| Vaccination | 6 | 2024 | 3278 | 0.130 |
Why?
|
| Plasma Cells | 1 | 2017 | 591 | 0.120 |
Why?
|
| Hypertension | 1 | 2013 | 8480 | 0.120 |
Why?
|
| Receptor Cross-Talk | 1 | 2013 | 119 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2021 | 4386 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2024 | 1479 | 0.110 |
Why?
|
| Genetic Vectors | 1 | 2021 | 3420 | 0.100 |
Why?
|
| Cell Separation | 1 | 2017 | 1751 | 0.100 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 479 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2013 | 23403 | 0.090 |
Why?
|
| Vasodilation | 1 | 2013 | 944 | 0.090 |
Why?
|
| Renin-Angiotensin System | 1 | 2013 | 759 | 0.080 |
Why?
|
| AIDS Vaccines | 3 | 2021 | 938 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.080 |
Why?
|
| Injections, Intramuscular | 2 | 2019 | 552 | 0.080 |
Why?
|
| South Africa | 2 | 2023 | 1731 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2017 | 5974 | 0.070 |
Why?
|
| Humans | 22 | 2024 | 744343 | 0.070 |
Why?
|
| Interferon-gamma | 2 | 2023 | 3206 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 9274 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 9438 | 0.060 |
Why?
|
| Hemagglutinins | 1 | 2024 | 117 | 0.060 |
Why?
|
| Viral Fusion Proteins | 1 | 2023 | 95 | 0.060 |
Why?
|
| Vaccines, Inactivated | 1 | 2024 | 184 | 0.060 |
Why?
|
| Inflammation | 2 | 2022 | 10638 | 0.060 |
Why?
|
| Tuberculin Test | 1 | 2023 | 214 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2024 | 342 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2020 | 1836 | 0.050 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2023 | 279 | 0.050 |
Why?
|
| Systems Analysis | 1 | 2022 | 172 | 0.050 |
Why?
|
| Shigella flexneri | 1 | 2022 | 132 | 0.050 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2023 | 139 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10262 | 0.050 |
Why?
|
| Nucleocapsid | 1 | 2021 | 59 | 0.050 |
Why?
|
| Bangladesh | 1 | 2023 | 687 | 0.050 |
Why?
|
| Vaccines, Conjugate | 1 | 2022 | 333 | 0.050 |
Why?
|
| BCG Vaccine | 1 | 2022 | 369 | 0.040 |
Why?
|
| Cross Reactions | 1 | 2022 | 841 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2022 | 758 | 0.040 |
Why?
|
| Serologic Tests | 1 | 2021 | 374 | 0.040 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
| Injections, Intradermal | 1 | 2018 | 117 | 0.040 |
Why?
|
| Pneumococcal Vaccines | 1 | 2022 | 391 | 0.040 |
Why?
|
| Interleukin-23 | 1 | 2020 | 193 | 0.040 |
Why?
|
| Adult | 6 | 2022 | 214055 | 0.040 |
Why?
|
| Tetanus Toxin | 1 | 2017 | 49 | 0.040 |
Why?
|
| Seasons | 1 | 2024 | 1493 | 0.040 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2017 | 363 | 0.040 |
Why?
|
| Enzyme-Linked Immunospot Assay | 1 | 2017 | 130 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2021 | 1099 | 0.040 |
Why?
|
| Tetanus Toxoid | 1 | 2017 | 193 | 0.040 |
Why?
|
| Electroporation | 1 | 2018 | 251 | 0.040 |
Why?
|
| Blood Preservation | 1 | 2017 | 177 | 0.040 |
Why?
|
| Middle Aged | 5 | 2022 | 213383 | 0.040 |
Why?
|
| Male | 7 | 2023 | 350118 | 0.040 |
Why?
|
| Hepatitis B Vaccines | 1 | 2017 | 194 | 0.040 |
Why?
|
| Diarrhea | 1 | 2023 | 1348 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2022 | 1053 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1357 | 0.030 |
Why?
|
| Young Adult | 4 | 2022 | 56430 | 0.030 |
Why?
|
| Muscles | 1 | 2019 | 1614 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 1475 | 0.030 |
Why?
|
| DNA Primers | 1 | 2018 | 2892 | 0.030 |
Why?
|
| Female | 6 | 2022 | 380194 | 0.030 |
Why?
|
| Antibodies | 1 | 2022 | 2460 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2021 | 1900 | 0.030 |
Why?
|
| United States | 1 | 2021 | 69872 | 0.030 |
Why?
|
| Cryopreservation | 1 | 2017 | 670 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1607 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 1678 | 0.030 |
Why?
|
| Protein Binding | 1 | 2022 | 9386 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2022 | 3848 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2017 | 4204 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3474 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
| Aged | 3 | 2023 | 163280 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15076 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5097 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4479 | 0.020 |
Why?
|
| Child | 2 | 2023 | 77709 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 15540 | 0.010 |
Why?
|
| Infant | 1 | 2022 | 35136 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 41006 | 0.010 |
Why?
|
| Time Factors | 1 | 2021 | 40075 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 168757 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 39050 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 15165 | 0.010 |
Why?
|
| Mice | 1 | 2019 | 81183 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 85781 | 0.010 |
Why?
|
Concepts
(134)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(23)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_